-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Explaining the Features and Value of the FACS Platform
Author:
InnoModels
Release time:
2024-06-14
With its leading-edge flow cytometry (FACS) technology platform, InnoModels Biotechnology offers unprecedented solutions for research, drug discovery, immunotherapy, and clinical diagnostics, etc. The FACS platform, with its unique advantages, enables researchers to analyze cells more efficiently and accurately, thus advancing the development of bioscience.
One of the most notable features of the FACS platform is its highly flexible multi-parameter analysis. The platform utilizes a multi-channel laser and fluorescent label detection system that enables researchers to simultaneously analyze multiple cellular markers in a single experiment. This capability provides researchers with a more comprehensive and in-depth characterization of cells, which helps to more accurately understand the biology of cells, and thus advances scientific research. Whether in immunophenotyping, cell cycle studies, or stem cell research, FACS technology can play an important role.
In addition, the FACS platform has demonstrated a wide range of applications. Whether it is basic science research, drug development and immunotherapy, the platform provides strong support. Its instruments and kits are designed to take into account the needs of various cell types and research directions, thus providing researchers with a wealth of options. By working closely with customers, InnoModels Biotechnology is also able to provide customized solutions to meet the needs of research projects in different fields.

On the basis of the FACS platform, InnoModels Biotechnology has also developed a cell-based in vitro assay platform, which demonstrates unique advantages in microbial detection. The platform is capable of quickly and accurately identifying microorganisms such as bacteria, viruses and fungi, and is easy to operate without the need for special skills and equipment. In addition, the platform is highly sensitive and accurate, so that even trace amounts of microorganisms will not be missed, thus avoiding false alarms or misjudgments. This allows the platform to have a wide range of applications in the medical field for disease treatment and monitoring, as well as in environmental protection and food safety.
Overall, with its highly flexible multi-parameter analysis, wide range of application areas, and unique in vitro detection capability, InnoModels' FACS platform provides strong support for bioscience research and technology applications. It not only provides researchers with more comprehensive and in-depth cell characterization tools, but also promotes the progress of bioscience research. Meanwhile, the platform also plays an important role in many fields such as disease treatment, environmental monitoring, food safety, etc., demonstrating its wide application value.
In the future, with the continuous development of bioscience and the advancement of technology, the FACS platform of InnoModels Biotechnology is expected to continue to play a greater role. Its accurate, efficient and comprehensive analytical capabilities, as well as its adaptability to different research fields, have made the platform an important position in the field of biological sciences. We expect that InnoModels Biotechnology will continue to innovate and improve its FACS platform to provide more and better solutions for bioscience research and applications.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd